These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 33546396)

  • 1. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market.
    Lee KJ; Lu SL
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
    Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
    Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESG Performance and Stock Price Volatility in Public Health Crisis: Evidence from COVID-19 Pandemic.
    Zhou D; Zhou R
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smog, media attention, and corporate social responsibility-empirical evidence from Chinese polluting listed companies.
    Xiong G; Luo Y
    Environ Sci Pollut Res Int; 2021 Sep; 28(34):46116-46129. PubMed ID: 33410010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indifferent to CSR performance? Market liberalization brings about changes.
    Zhou H; Xu L
    Heliyon; 2023 Nov; 9(11):e22172. PubMed ID: 38045161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational safety and health aspects of corporate social responsibility (CSR) in Japanese companies listed on the Tokyo Stock Exchange (TSE) first section.
    Kawashita F; Taniyama Y; Hwi SY; Fujisaki T; Kameda T; Mori K
    J Occup Health; 2005 Nov; 47(6):533-9. PubMed ID: 16369117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stock Market Reactions to COVID-19 Pandemic Outbreak: Quantitative Evidence from ARDL Bounds Tests and Granger Causality Analysis.
    Gherghina ȘC; Armeanu DȘ; Joldeș CC
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32942766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A business model predicting the impact of live-stream marketing on firms' stock price - An event study.
    Luo S; Shyu ML; Silalahi ADK; Shih IT
    Heliyon; 2022 Dec; 8(12):e12522. PubMed ID: 36593856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of socially responsible firms during the COVID-19 crisis and trading behavior by investor type: Evidence from the Korean stock market.
    Lee S; Lee D; Hong C; Park MH
    Financ Res Lett; 2022 Mar; 45():102660. PubMed ID: 35002551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies.
    Hwang TJ
    PLoS One; 2013; 8(8):e71966. PubMed ID: 23951273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corporate social responsibility, financing constraints, and corporate carbon intensity: new evidence from listed Chinese companies.
    Chen P
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40107-40115. PubMed ID: 36609966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COVID-19 Outbreak and Affected Countries Stock Markets Response.
    Liu H; Manzoor A; Wang C; Zhang L; Manzoor Z
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32325710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural model of corporate social responsibility. An empirical study on Mexican SMEs.
    Ríos-Manríquez M; Ferrer-Ríos MG; Sánchez-Fernández MD
    PLoS One; 2021; 16(2):e0246384. PubMed ID: 33592072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantity, Quality, and Performance of Corporate Social Responsibility Information Disclosure by Listed Enterprises in China: A Regional Perspective.
    Zhang H; Zhang Z; Tan A; Steklova E
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32230705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of COVID-19 on cultural industries: An empirical research based on stock market returns.
    Zhang R; Ji H; Pang Y; Suo L
    Front Public Health; 2022; 10():806045. PubMed ID: 36187644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of 2020 stock market crash: The COVID-19 induced extreme event.
    Mahata A; Rai A; Nurujjaman M; Prakash O; Prasad Bal D
    Chaos; 2021 May; 31(5):053115. PubMed ID: 34240931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.